What Does Unexpected Suboptimal Response During Ovarian Stimulation Suggest, an Overlooked Group?
Wang B, Liu W, Liu Y, Zhang W, Ren C, Guan Y.
Front Endocrinol (Lausanne). 2021 Dec 22;12:795254. doi: 10.3389/fendo.2021.795254. eCollection 2021.
Association of 'normal' early follicular FSH concentrations with unexpected poor or suboptimal response when ovarian reserve markers are reassuring: a retrospective cohort study.
Del Gallego R, Lawrenz B, Ata B, Kalafat E, Melado L, Elkhatib I, Fatemi H.
Reprod Biomed Online. 2024 Mar;48(3):103701. doi: 10.1016/j.rbmo.2023.103701. Epub 2023 Nov 10.
Development and validation of a prediction model for suboptimal ovarian response in polycystic ovary syndrome (PCOS) patients undergoing GnRH-antagonist protocol in IVF/ICSI cycles.
Xu X, Jiang Y, Du J, Sun H, Wang X, Zhang C.
J Ovarian Res. 2024 May 28;17(1):116. doi: 10.1186/s13048-024-01437-w.
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.
Morgan RD, Wang X, Barnes BM, Spurgeon L, Carrot A, Netto D, Hasan J, Mitchell C, Salih Z, Desai S, Shaw J, Winter-Roach B, Schlecht H, Burghel GJ, Clamp AR, Edmondson RJ, You B, Evans DGR, Jayson GC, Taylor SS.
Br J Cancer. 2024 Dec;131(12):1919-1927. doi: 10.1038/s41416-024-02874-6. Epub 2024 Nov 16.
Clinical Features and Management of Suboptimal Ovarian Response During in vitro Fertilization and Embryo Transfer: Analysis Based on a Retrospective Cohort Study.
Yan Y, Qu R, Ma X, Qin S, Chen L, Ni X, Yang R, Wang Y, Li R, Qiao J.
Front Endocrinol (Lausanne). 2022 Jul 22;13:938926. doi: 10.3389/fendo.2022.938926. eCollection 2022.
Elective Single Cleavage-Stage Embryo Transfer in IVF Patients with Suboptimal Ovarian Response is Not Detrimental to Cumulative Pregnancy and Reduces Multiple Pregnancy Rates.
Paffoni A, Cesana S, Corti L, Wyssling H, Kunderfranco A, Bianchi MC.
J Obstet Gynaecol India. 2023 Aug;73(4):329-335. doi: 10.1007/s13224-023-01768-6. Epub 2023 Jun 7.
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.
Pierre ME, Manneh R, Hernández A, Rodríguez J, Fletcher AV, Ramírez HM, Niño OM, Gómez DA, Sanabria D, Contreras F, Pieschacón JR, Calderón PH.
Rev Colomb Obstet Ginecol. 2024 Jun 14;75(1):4094. doi: 10.18597/rcog.4094.
Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
Oudshoorn SC, van Tilborg TC, Hamdine O, Torrance HL, Eijkemans MJC, Lentjes EGWM, Lambalk CB, Broekmans FJM.
Hum Reprod. 2017 Aug 1;32(8):1701-1709. doi: 10.1093/humrep/dex222.
Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy.
Nikkhoi SK, Li G, Eleya S, Yang G, Vandavasi VG, Hatefi A.
Front Immunol. 2023 Jan 6;13:1039969. doi: 10.3389/fimmu.2022.1039969. eCollection 2022.
Ovarian response to stimulation and suboptimal endometrial development are associated with adverse perinatal outcomes in intracytoplasmic sperm injection cycles.
Borges E Jr, Zanetti BF, Braga DPAF, Setti AS, Figueira RCS, Iaconelli A Jr.
JBRA Assist Reprod. 2019 Apr 30;23(2):123-129. doi: 10.5935/1518-0557.20190001.
